Drugs Made In America Acquisition Corp Units
DMAAU
2 hedge funds and large institutions have $121K invested in Drugs Made In America Acquisition Corp Units in 2026 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.
2.7% less ownership
Funds ownership: 2.76% → 0.06% (-2.7%)
60% less funds holding
Funds holding: 5 → 2 (-3)
98% less capital invested
Capital invested by funds: $5.77M → $121K (-$5.64M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KC
Kryger Capital
London,
United Kingdom
|
-$3.04M |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$1.37M |
| 3 |
CS
Clear Street
New York
|
-$855K |
| 4 |
RCM
Robinson Capital Management
Grosse Pointe Farms,
Michigan
|
-$315K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$68.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CS
1
Clear Street
New York
| $105K | -$855K | -81,219 | -89% |
|
|
2
UBS Group
Zurich,
Switzerland
| $16K | -$68.4K | -6,500 | -81% |
|
|
KC
3
Kryger Capital
London,
United Kingdom
| – | -$3.04M | -303,810 | Closed |
|
|
WAM
4
Wolverine Asset Management
Chicago,
Illinois
| – | -$1.37M | -130,000 | Closed |
|
|
RCM
5
Robinson Capital Management
Grosse Pointe Farms,
Michigan
| – | -$315K | -30,000 | Closed |
|
DMAAU Hedge Fund Activity: Q1 2026 in Review
2 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Drugs Made In America Acquisition Corp Units (DMAAU) for Q1 2026, worth a combined $121K — down 98% from $5.77M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of DMAAU and 0 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was Kryger Capital, exiting entirely with an estimated $3.04M sold.
- 2 institutional investors held Drugs Made In America Acquisition Corp Units (DMAAU) as of Q1 2026, down from 5 in Q4 2025.
- Funds reported $121K of Drugs Made In America Acquisition Corp Units stock for Q1 2026, down 98% quarter-over-quarter.
- 0 funds opened new Drugs Made In America Acquisition Corp Units positions in Q1 2026 and 3 closed out, a net change of -3 holders.
- The largest Drugs Made In America Acquisition Corp Units seller in Q1 2026 was Kryger Capital, an estimated $3.04M sold.
Based on aggregated 13F filings for Q1 2026.